Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000402989 | SCV000558916 | likely benign | Fanconi anemia | 2024-01-19 | criteria provided, single submitter | clinical testing | |
Cancer Genomics Group, |
RCV001030549 | SCV001193593 | uncertain significance | Hereditary breast ovarian cancer syndrome | 2019-05-01 | criteria provided, single submitter | research | |
Sema4, |
RCV002256202 | SCV002529860 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-05-29 | criteria provided, single submitter | curation | |
Gene |
RCV003229827 | SCV003927595 | uncertain significance | not provided | 2022-11-23 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 32566746) |
Prevention |
RCV004544559 | SCV004766094 | likely benign | FANCM-related disorder | 2022-12-23 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |